Tag: Clinical
-
Amwell Receives Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition for Technology-Enabled Care Platforms
Amwell® is transforming virtual care delivery through its unified Amwell Platform, combining interoperability, clinical integration, and intelligent orchestration to improve access, efficiency, and outcomes.SAN ANTONIO, Sept. 5, 2026 /PRNewswire/ — As healthcare organizations move beyond fragmented…
-
AtomVie Global Radiopharma Celebrates the Grand Opening of its New State-of-the-Art Radiopharmaceutical Manufacturing Facility in Hamilton, Ontario
HAMILTON, ON, Sept. 4, 2026 /PRNewswire/ – AtomVie Global Radiopharma (AtomVie), a leading global Contract Development and Manufacturing Organization (CDMO) in the radiopharmaceutical industry, today celebrated the Grand Opening of its new purpose-built, state-of-the-art manufacturing facility at 10…
-
ZEISS elevates ophthalmic workflows at ESCRS with new surgical and digital advancements
ZEISS Medical Technology will showcase new clinical and digital workflow innovations at ESCRS, including:New ZEISS IOL offering is the world’s first bitoric hydrophobic monofocal IOL with a non-constant asphericity profile design to treat cataracts while simultaneously correcting astigmatism.The EVA…
-
FutureCeuticals , Inc. (FC) and Aura Scientific Resolve Coffee Fruit Patent Dispute, Recognize FC Patent Rights, and Initiate Seamless Transition to CognatiQ®
MOMENCE, Ill., Sept. 3, 2026 /PRNewswire/ — FutureCeuticals, Inc. (FC) and Aura Scientific (Aura) are pleased to announce the resolution of FutureCeuticals’ patent and trademark suit related to Aura’s NeuroRush® ingredient and FutureCeuticals’ whole coffee fruit extract marketed under the tradename…
-
NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
Round led by Neurimmune and Pureos, with participation from existing and new investors; complemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life – Spinal Cord Research Foundation.SCHLIEREN, Switzerland, Sept. 2, 2026 /PRNewswire/ — NovaGo Therapeutics AG, a clini…
-
BTL Establishes New Laser Division and Introduces EXOLASE ONE® – The World's First Fused Erbium Laser
Proprietary technology fuses multiple wavelengths into a single beam to set a new standard of care in laser facial rejuvenation.PRAGUE, Sept. 2, 2026 /PRNewswire/ — BTL, a global leader in advanced energy-based medical and aesthetic technologies, today announced a major milestone in its corporate h…
-
Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
PALMA DE MALLORCA, Spain, July 24, 2026 /PRNewswire/ — Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV) in the company’s Phase 2b/3 clinical trial of its …
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.